I'd like to notice the framing of the same issue in two cases:
1. covid19 can potentially cause irreversible damage to brain with blood clots (the reader is encouraged to focus on grave consequencies and ignore the low likehood of those issues)
2. the J&J vaccince has an extremely low possibility to cause blood knots, so CDC recommends to play it safe (the reader is encouraged to focus on the low likehood of adverse effects and ignore the severity of those effects)
Edit: I'd add that in both cases the news outlet wants to bypass the reader's rationality and reach directly the emotional part of the brain, so the reader would make the decision based on feelings.
> This is also a very rare side effect of the J&J vaccine
Not just J&J [1]
>SINGAPORE - There are 10 suspected cases of cerebral venous thrombosis (CVT), or blood clot in the brain, among those who have received the Pfizer and Moderna vaccines for Covid-19 in Singapore.
Here in the US we prolong seeking out treatment until it's really serious. Seems like the antivirals may not help much here. But I suppose other treatments have likely been developed in the last year or two, too.
How many are not anti-vax in general, but anti-spike? Isn't the safety of a vaccine supposed to be assumed controversial for a few years, under normal circumstances?
> Moderna expects to deliver between 700 million and 800 million COVID-19 vaccine doses at the 100 µg dose level in 2021, down from the previous guidance of 800 million to 1 billion doses.
Will 700 million recipients of 100 µg doses be informed that Moderna booster's mRNA content has been reduced by 50%, from 100 µg to 50 µg? Pfizer booster is unchanged at 30 µg, same as Pfizer 1st and 2nd shots, https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-....
Can new recipients of Moderna receive the 50 µg dose, which is 166% of Pfizer's mRNA dose, rather than 300%?
Germany, France, Finland, Sweden, Denmark and Norway suspended Moderna for people under 30.
>Frontera led a study that found that more than 13% of hospitalized COVID-19 patients had developed a new neurological disorder soon after being infected. A follow-up study found that six months later, about half of the patients in that group who survived were still experiencing cognitive problems.
The infection hospitalization rate for the Alpha variant was about 7% [0] so 50% of 13% of 7% means... 0.46% of patients may experience a new serious neurological complication that persists past 6 months.
Where "patients" is those aged 55-77 (with lower body mass indices, more past history of dementia, stroke and seizure, worse SOFA scores during hospitalization and higher rates of acute renal failure) [1], and...
>though we identified high rates of disability among both neurological COVID-19 patients and controls, this study was not designed to determine whether the deficits measured by these metrics are static or represent ongoing injury as suggested by some “long-hauler” and post-COVID literature. Since cognitive impairment and mood abnormalities occur in over 50% of ARDS survivors, it is possible that the level of disability we are documenting is not specific to SARS-CoV-2, but rather a result of factors related to critical viral illness.
Stroke threatens the brain. We have a million of them a year. Been here since the start of modern medicine. A neurological therapeutic is complicated because of neurotransmitters, chemical synapses, and the lack of neural regeneration.
13 comments
[ 3.1 ms ] story [ 35.5 ms ] threadThis is also a very rare side effect of the J&J vaccine, https://www.cdc.gov/coronavirus/2019-ncov/videos/vaccines/vi...
1. covid19 can potentially cause irreversible damage to brain with blood clots (the reader is encouraged to focus on grave consequencies and ignore the low likehood of those issues)
2. the J&J vaccince has an extremely low possibility to cause blood knots, so CDC recommends to play it safe (the reader is encouraged to focus on the low likehood of adverse effects and ignore the severity of those effects)
Edit: I'd add that in both cases the news outlet wants to bypass the reader's rationality and reach directly the emotional part of the brain, so the reader would make the decision based on feelings.
Not just J&J [1]
>SINGAPORE - There are 10 suspected cases of cerebral venous thrombosis (CVT), or blood clot in the brain, among those who have received the Pfizer and Moderna vaccines for Covid-19 in Singapore.
[1] https://www.straitstimes.com/singapore/10-suspected-cases-of...
Fortunately, multiple early treatments are available, depending on country.
> Moderna expects to deliver between 700 million and 800 million COVID-19 vaccine doses at the 100 µg dose level in 2021, down from the previous guidance of 800 million to 1 billion doses.
Will 700 million recipients of 100 µg doses be informed that Moderna booster's mRNA content has been reduced by 50%, from 100 µg to 50 µg? Pfizer booster is unchanged at 30 µg, same as Pfizer 1st and 2nd shots, https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-....
Can new recipients of Moderna receive the 50 µg dose, which is 166% of Pfizer's mRNA dose, rather than 300%?
Germany, France, Finland, Sweden, Denmark and Norway suspended Moderna for people under 30.
The infection hospitalization rate for the Alpha variant was about 7% [0] so 50% of 13% of 7% means... 0.46% of patients may experience a new serious neurological complication that persists past 6 months.
Where "patients" is those aged 55-77 (with lower body mass indices, more past history of dementia, stroke and seizure, worse SOFA scores during hospitalization and higher rates of acute renal failure) [1], and...
>though we identified high rates of disability among both neurological COVID-19 patients and controls, this study was not designed to determine whether the deficits measured by these metrics are static or represent ongoing injury as suggested by some “long-hauler” and post-COVID literature. Since cognitive impairment and mood abnormalities occur in over 50% of ARDS survivors, it is possible that the level of disability we are documenting is not specific to SARS-CoV-2, but rather a result of factors related to critical viral illness.
[0] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895685/
[1] https://www.jns-journal.com/article/S0022-510X(21)00180-5/fu...